RAD BioMed

"Who said that a virus is bad? When Big Data, supercomputing and biology meet to heal diseases" - Meet Tahel Altman, MD and CEO of SynVaccine at this interview in Geektime גיקטיים.

https://goo.gl/pn1jrY

מי אמר שווירוס זה רע? כשביג דאטה, מחשוב על וביולוגיה נפגשים כדי לרפא מחלות עיצוב ותכנון מערכות ביולוגיות שלמות, פיתוח וירוסים חיוניים ומציאת פתרונות למחלות חשוכות מרפא – הביולוגיה הסינתטית צוברת תאוצה בקרב חברות סטארט-אפ וקרנות הון סיכון מסביב לעולם. אז האם ישראל בדרך להפוך להאב של חברות בתחום? ראיון עם ד"ר תהל אלטמן, מנכ"לית SynVaccine, שהחליפה את חדר הטיפולים בבית החולים...

Meet our portfolio companies! >> Moebius Medical

Moebius lead a product for osteoarthritis of the knee, MM-II, leverages the physical properties of proprietary liposomes to lubricate the joint and reduce friction and wear, thus leading to joint pain reduction.

At the end of 2016 Sun Pharma & Moebius Medical sign exclusive global licensing deal to develop novel liposomal non-opioid pain product for osteoarthritis.

Visit Moebius Medical site: http://moebiusmedical.com/

Meet our portfolio companies! >> Synvaccine

Meet the Company that develops a platform with a potential to transform future medicine in one of the hottest areas of bioscience: synthetic biology.
Synvaccine has grown and matured in the accelerator and is now in the development stage. It will offer a revolution in immunotherapy for cancer and infectious diseases by means of synthetic biology.

Visit Synvaccine site: https://www.synvaccine.com/
Watch this video: https://youtu.be/nBbj6pM3AwU

"Amir is probably one of the most active and productive serial entrepreneurs working in Israel today," says David Zigdon, CEO of the RAD BioMed Accelerator.
In an interview published yesterday in Globes, serial entrepreneur Dr. Amir Belson talks about his search for a new colonoscopy system and how his search has led to founding Radiaction in our accelerator.
We take pride in Dr. Belson's work and the joint word we did until Radiaction was founded.
David Zigdon, CEO of RAD BioMed Accelerator added, "RAD BioMed is always on the lookout for new entrepreneurs who combine a breakthrough product and a strong team who is resourceful, technologically and business-savvy and entrepreneurial."

Read the article here:
‏https://goo.gl/pAvSVd

Meet our portfolio companies! >>
Glaucoma is the leading cause of irreversible blindness globally.
Meet our portfolio company -- BELKIN Laser -- that is developing a one-second glaucoma laser treatment which will become the first line solution for millions of glaucoma patients around the world.

Visit BELKIN Laser site: http://www.belkin-laser.com
Watch this video: https://youtu.be/Im1x8JZ22yI

Meet our portfolio companies! >>
The Company which revolutionizes the care of chronic CHF patients: Meet --Vectorious Medical Technologies--: founded in 2011, it grew up in our incubator and enables optimal CHF patient management with an innovative, miniature, wireless sensory implant.

Click LIKE and share so that more chronic CHF patients learn about the solution for their condition!

Visit Vectorious Medical Technologies site: www.vectoriousmedtech.com

RAD BioMed companies are a source of hope for millions of patients across the globe. We are proud to share with you the moving story of Allaina, whose life was transformed by a development of SoftWheel Ltd., one of our incubator companies.

SoftWheel by Numotion - Allaina's Story SoftWheel by Numotion is an innovative in-wheel suspension system designed to absorb impact and provide a smoother, more comfortable ride. They quite literal...